Abstract-One of the major fallouts of the human genome project relates to the investigation of the molecular mechanisms of diseases. Identification of genes which are involved in a specific pathological process and characterization of their interactions is of fundamental importance for supporting the drug design processes. Discovery of targets and the related experimental validation is a critical step in the development of new drugs. The new experimental methods for gene expression analysis, such as microarray technology, allows for the concurrent evaluation of the expression of multiple genes. The outcome of these new experimental methods requires a subsequent validation of the gene function by using in vitro or in vivo models. In the last decade, one of the most promising methodologies for the investigation of gene function relies upon antisense oligonucleotides (ASO). The crucial step in antisense experiment design is the characterization of the nucleotide domains that can efficiently be targeted by this kind of synthetic molecule. At present, no standardized procedures for target selection are available. In this paper, we propose an integrative approach to ASO target selection: the proposed tool Automatic Gene Walk (AgeWa) combines a neural filter with database mining for the prediction of the optimal target for antisense action.
I. INTRODUCTION
T HE investigation of the biological functionality of unannotated genomic sequences is one of the major hints in the postgenomic era. New high-throughput techniques, such as microarray [1] or the electronic dot blot [2] , allow for the concurrent determination of the expression of a large number of genes (the microarray) or of the expression of a single gene in multiple samples (the e-dot blot). The outcome of microarrays experiments requires to be validated by in vitro or in vivo experiments. At present, different approaches are available to perform this kind of analysis, one of the most promising being based upon the application of antisense oligonucleotide (ASO) technology [3] . This technique is characterized by the following advantageous features. 1) Efficiency: it is possible to target unfinished sequences.
2) Versatility: all of the gene can be blocked. 3) Specificity: it can inhibit the gene function by taking into account subtle compositional variations (single nucleotide polymorphism). An ASO is a short and chemically modified stretch of nucleotides that is able to inhibit gene expression by interfering with the mRNA processing or by blocking the transcription phase (antigene approach). The basic principle of ASO action is quite simple: the molecule forms a duplex with a specific domain along the mRNA or DNA molecule. Any tract of a nucleotide sequence can be a target for an antisense molecule; in fact, only a limited number of domains can be hybridized with high efficiency. The selection of optimal targets is a critical step in the design of an antisense experiment.
There are different types of potential targets, that are specific for RNA or DNA function inhibition: to block the RNA one can decide to target the pre mRNA splicing or the RNA transport; otherwise one can select specific motifs on the sequence, such as the catabolite activator protein (CAP) site or 3 untranslated region (UTR). Direct inhibition of the function of the gene can be obtained by using oligonucleotides versus splicing sites on the major groove or versus specific transcription factor binding sites. There are some prerequisites for ASO design:
1) knowledge about the gene function; 2) identification of highly specific targets on the sequence; 3) evaluation of the functional relevance of the selected targets; 4) evaluation of the metabolic fate and toxicity and side effects of the ASO. At present, no standardized procedures are available for the recognition of the ASO target; some approaches are founded on the direct recognition of nucleotide motifs along the linear sequence, and other methods investigate the capability of binding structured RNA. The first class requires a trial of a very large number of oligonucleotides, whereas other methods, founded on conformational properties, give only a set of suboptimal conformations that do not ensure a really high efficiency of gene function inhibition. In this paper, we propose an integrative approach to support the design of antisense experiment. The method combines machine learning, database mining, conformational analysis, and hybridization simulation for the identification of optimal antisense targets.
II. METHODOLOGY
The available computational tools for ASO target selection require a huge amount of computer time because they are essentially based on molecular mechanics or quantum mechanic simulation [4] . The development of bioinformatics support for antisense experiment design requires the integration of different 1536-1241/02$17.00 © 2002 IEEE kind of information: structure, kinetics, expression, and biochemical data.
Antisense target selection can be viewed, under a computer science perspective, as a "knowledge discovery process." Machine learning methods allow to integrate different sources of data in order to investigate the intrinsic statistical relations among them.
On the basis of current knowledge, an ASO experiment is characterized by the hybridization efficiency of the oligonucleotide, the analysis of the conformational and metabolic constrains that influence the antisense activity, and the evaluation of the effects on the gene function inhibition. From this perspective, we have developed the Automatic Gene Walking (AgeWa) tool for the support of antisense experiment design. A basic system to face this task requires the integration of bioinformatics, cheminformatics, and mathematical modeling. The AgeWa system has been developed by using a modular architecture to allow the integration of other information possibly available in the future. The basic structure of our software is constituted by four modules: 1) machine learning; 2) feature extraction and selection; 3) database screening; 4) biophysical characterization. The machine learning kernel is founded on the "unsupervised" learning algorithm Winner Take All (WTA), described in [5] .
The choice of this kind of classifier depends on the lack of available robust knowledge about ASO sequences that would be needed in the perspective of building a reliable training set for the application of supervised classifiers. The network topology that is required for data partitioning is automatically defined according to the length of the sequence. Given a sequence of length , the training set for classification is obtained by segmentation of with a one-base sliding window of dimensionality (for this application we used 6). The learning phase follows the canonical WTA approach [6] . Each input vector has been normalized at 1; distances were measured by applying weighted Euclidean metrics [6] .
The feature extraction and selection module is activated when the learning module terminates its execution. This part of the software performs two different tasks. The first one is the characterization of each pattern of the training set by a mechanical statistic parameter, the electroionic interaction potential (EIIP) [7] . The second task is the actual feature selection and extraction. The informative principle facing this task is the generation of an EIIP landscape for the processed sequence; it is constituted by the ensemble of the signatures that respectively represent the region of maximal and of minimal EIIP value. A signature is obtained by sequence synthesis [8] by using the procedure described in Table I .
Features selected by the program are then characterized by their biophysical properties; we evaluated four parameters for each signature: 1) EIIP; 2) melting temperature ; 3) ; 4) hybridization score (HS). [9] .
The HS has been introduced here to estimate the capability of the signature to hybridize. Table II shows the pseudocode for the signature characterization.
The four parameters allow a combined view of statistical characteristics and thermodynamics; at present, the selection of signatures for database mining is founded on the satisfaction of the following simple empirical rule: R Max EIIP Max HS Then select signature
Signatures selected on the basis of this rule are then submitted to a database mining tool in order to evaluate the level of potential interference with other genes.
The database screening is currently performed by a remote Basic Local Alignment Search Tool (BLAST) [12] search on the database of sequence-tagged sites (dbSTS) [13] that contains experimentally tested genomic sequences, at the U.S. National Center for Biotechnology Information (NCBI) Web site. 1 The general approach for database searching is to identify sequence similarity in order to initially evaluate the potential functional relation of a custom sequence. In the present application, a high level of similarity is evidence for low hybridization specificity because it shows that the oligonucleotide is able to target other genes.
The outcome of the BLAST alignment includes a statistic parameter, the E-value, that is related to the similarity score. It is commonly used to estimate the level of actual similarity between the custom sequence and sequences that are stored in the database; lower E-values ensure low levels of chance similarity.
To estimate the specificity level of each potential oligonucleotide, we set an E-value threshold of 10e : we rejected all signatures having an E-value lower than this cutoff value.
III. RESULTS
We have tested AgeWa on a set of genomic sequences that were selected due to the availability of an experimental tested ASO and reported in the literature. In the following tables, sequences are identified by their database accession number, as reported in the literature.
Results of this preliminary analysis are shown in the following tables; they summarize the distribution of the maximal and minimal EIIP signatures screened by the program.
For clarity, we have also reported the displacement of the oligo from the coding region, as reported in the specific database entry, and signatures are classified according to it. For sake of simplicity, we have defined three main classes with reference to the coding sequence: 1) signatures upstream from the starting point of the coding sequence; 2) signatures in the coding sequence; 3) signatures downstream from the terminal codon of the coding sequence. The number of selected signatures depends on the two length thresholds ( and ); we have assigned a default value to these parameters, according to the size of experimentally tested ASOs (they are generally 12-30 nucleotide long). Tables I and II show a predominance of signatures related to the coding sequence.
It is important to note that some sequences do not have information about the position of the coding region: they are marked by an asterisk (*).
A sequence (D85375) has two exons (ex1 and ex2); in this case, the signature in the downstream region for ex1 corresponds to the upstream signature for ex2. Both tables show that the majority of signatures are related to the coding region.
To evaluate the correspondence between signatures and experimentally determined ASOs, we have summarized this correspondence in Tables III and IV ; in these tables, we have indicated with "ND" (not detected) the absence of correspondence between the experimental ASO and the predicted one. Tables V and VI show, for the sake of simplicity, only the position of the recognized nucleotide signature with the highest (Table V) and the lowest (Table VI) is reported in the third column. The asterisks identify the sequences without information about the position of the coding region.
The specificity of the signatures, evaluated by BLAST similarity search, has been reported for only some of those which are related to the maximal EIIP. We have summarized in Table VII the alignment score (BLAST E-values) and the parameter computed by the program for a sample of signature. 
IV. DISCUSSION
The results obtained by the proposed approach have evidenced the possibility that a combined application of a neural filter and a sequence alignment strongly reduces the number of putative targets for ASOs. Other approaches start from sequence alignment for the identification of conserved domains that can then be used for ASO design. The problem with this method is related to the identification of highly specific tags for each sequence. Our approach works essentially in a bottom-up way: first, we identify the signatures on the processed sequence, then we check their specificity.
Data shown here represent a preliminary test of the basic module of the AgeWa system. The criteria that have been used here were originally applied for the discrimination of singlepoint mutations. We have introduced a thermodynamic characterization for a more easy comprehension of results.
From the previous tables, it is interesting to point out that the majority of the potential targets are related to the coding regions; the maximal EIIP signatures seem to be more strongly related to high hybridization capability than the other. This relation is confirmed by the correspondence between the predicted target and the experimental one.
The use of the standard BLAST E-value is a relatively good approach for the signature's specificity, because we need to evaluate the nucleotide identity between the signature and a specified database entry.
The software gives a reduced set of signatures, and the experimental ASO is included in this set in the majority of the cases. The cases of not-detected signatures can depend on the length cutoff or the input dimensionality.
The lack of standardized procedures for ASO design is an important limiting factor for the possibility of defining general rules for ASO design. Consequently, we cannot be sure that selected oligonucleotides differing from those that are reported in the literature can equally inhibit a specific gene.
V. CONCLUSION
The design of antisense oligonucleotide is a complex task, the identification of optimal target is a crucial step for their therapeutic application and also for the efficient validation of the results obtained from the new highly automated techniques for massive screening of potential active compounds, high throughput screening (HTS) [14] .
In the perspective to increase the efficiency in the process of antisense experiment design, we need take into account both the structural both the functional information; the integration of these information can be performed by the development of an appropriate software environment. In this paper, we have described the kernel of an integrative software for antisense experiment design (AgeWa). This program allow to reduce the number of nucleotide signature that can be analysed by other tools or that can be directly experimentally tested.
The complete AgeWa system will be a hierarchical data mining procedure for the identification of optimal antisense targets; to identify these domains, we need to evaluate statistical, conformational, and kinetic data at once. The last level will be the experimental evaluation of the capability to block the gene function.
The knowledge discovery at the structural genomic level will give the "rule" needed to perform the basic screen, included the simulation of the hybridization capability.
The achievement of this goal depends on the possibility of accessing different structural and functional information that at the moment are not included in the system. The structural data allow the evaluation of the influence of the oligonucleotide conformation on the hybridization capability. The outcome of the structural level is the starting point for functional analysis. In this phase, the antisense approach needs to be complemented by experimental techniques such as the microarray or reverse transcription-polymerase chain reaction or otherwise by using in vivo models.
The modularity of AgeWa allows the performance of an integration of different modules that can perform analytical or database linking.
